Table I.
Variables | Spearman's rank correlation coefficient (Rho) | P-value |
---|---|---|
Age, years | 0.0954 | 0.0624 |
BMI | 0.0193 | 0.7075 |
Maximum IMT | 0.1703 | 0.0028 |
AST | 0.0054 | 0.9161 |
ALT | -0.0428 | 0.4051 |
ALP | 0.0647 | 0.228 |
LDH | 0.086 | 0.0986 |
tBil | -0.0226 | 0.6642 |
CHE | -0.1960 | 0.0009 |
γ-GTP | 0.0586 | 0.2677 |
TP | -0.0910 | 0.0797 |
ALB | -0.1727 | 0.0007 |
BUN | 0.034 | 0.5082 |
Creatinine | -0.0079 | 0.8783 |
eGFR | -0.0124 | 0.8154 |
UA | 0.069 | 0.2558 |
AMY | -0.0764 | 0.2537 |
T-CHO | -0.1567 | 0.0046 |
HDL-C | -0.0673 | 0.3106 |
TG | -0.1109 | 0.0814 |
Na | -0.0139 | 0.7877 |
K | -0.0994 | 0.054 |
Cl | -0.0989 | 0.055 |
CRP | 0.1395 | 0.0221 |
WBC | 0.0905 | 0.0783 |
RBC | -0.0673 | 0.1912 |
HGB | -0.0564 | 0.2737 |
HCT | -0.0626 | 0.2243 |
PLT | -0.0481 | 0.3503 |
BS | 0.1542 | 0.0039 |
HbA1c | -0.0250 | 0.6695 |
Smoking duration (years) | 0.1938 | 0.0002 |
Frequency of alcohol consumption (times/week) | 0.1174 | 0.0241 |
A correlation analysis was performed to identify the correlation between TSTD2 antibody levels and the clinical features of patients with ischemic stroke. Correlation coefficients (Rho) and P-values were calculated using Spearman's correlation analysis. Significant correlations (P<0.05) are marked in bold font. aCI, acute cerebral infarction; TSTD2, thiosulfate sulfurtransferase-like domain-containing 2; BMI, body mass index; IMT, intima-media thickness; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; tBil, total bilirubin; CHE, choline esterase; γ-GTP, γ-glutamyl transpeptidase; TP, total protein; ALB, albumin; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; UA, uric acid; AMY, amylase; T-CHO, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; CRP, C-reactive protein; WBC, white blood cell count; RBC, red blood cell count; HCT, hematocrit; PLT, platelet count; BS, blood sugar; HbA1c, hemoglobin A1c.